Workflow
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
BDSXBiodesix(BDSX) GlobeNewswire·2025-01-10 19:00

Grew full-year revenue to an estimated $71.3 million, an increase of 45%LOUISVILLE, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its preliminary financial results for the fourth quarter and year ended December 31, 2024 (fiscal 2024). The financial results included in this release pertaining to the fourth quarter and fiscal 2024 are preliminary, unaudited, and subject to final review and adjustment. Preliminary Unaudited Fourt ...